Weekender: The Supreme Court saved the ACA, again. It may not be the last word on challenges.

Signup | Forward Weekender June​ 26,​ 2021 | A roundup of this week's most read stories

BROUGHT TO YOU BY — ZS Transforming medtech customer engagement ZS research highlights the need to evolve and modernize the medtech engagement model. Read more to learn the key factors that will drive this change.   Reader Survey Closing Soon Do you have five minutes? In a few days we'll be closing out our third annual MedTech Dive reader survey and we'd love to hear your opinion. The feedback you provide will inform our journalism. And all respondents will be entered for a chance to win a $200 gift card. Take the survey As always, thanks for reading. Sean Griffey CEO Industry Dive Twitter | Email The Supreme Court saved the ACA, again. It may not be the last word on challenges. Will the 7-to-2 ruling put future efforts on ice? Even staunch backers of the law expect opponents to "come up with something." Philips recall could be $300M opportunity for ResMed: analysts The Baird analysts warned it's a heavy lift, suggesting hitting a $100 million to $300 million range would require about 10% to 20% of the impacted Philips devices to transition to ResMed. AdvaMed urges Biden to prioritize medical supplies as industries suffer shipping constraints CEO Scott Whitaker said transport challenges, including shipping container shortages and insufficient trucking capacity, have impeded the ability of medtechs to deliver products while also significantly driving up costs. MEDTECH DIVE TRENDLINE MedTech sales in a post-pandemic world Discover how leading MedTech companies are recovering from the pandemic’s effect on 2020 sales in this new Trendline. Boston Scientific spends $295M to snap up rest of cardiac ablation maker Farapulse The deal adds to the medtech's electrophysiology portfolio in an increasingly competitive space that includes Medtronic and Johnson & Johnson. UnitedHealthcare skimping on COVID-19 test pay: California doctors group The California Medical Association says UnitedHealthcare still is not covering the cost of all COVID-19 diagnostic testing, despite state and federal guidelines that require the services to be provided at no cost to patients. PerkinElmer, Qiagen latest medtechs to target rapidly growing CRISPR market Qiagen launched new products to enable researchers to better analyze the gene editing impact of their work, while PerkinElmer bought viral vector gene delivery company SIRION Biotech to complement its CRISPR portfolio.   Recommended For You Improve your recommendations: click here to update your profile. Deep Dive Legacy medical devices, growing hacker threats create perfect storm of cybersecurity risks Aging medtech and increasingly sophisticated criminals are leaving hospitals highly vulnerable to attacks. How Are MedTech Leaders Driving Innovation? The pandemic created opportunities for innovation in the MedTech space — and the rapid pace is likely to continue. Learn how to build on this momentum in this playbook. Download Now From Our Library Trendline How medtechs are navigating the sales environment after the pandemic Webinar - on demand Building a Culture of Quality to Help Your Business Thrive MasterControl View all resources Best of What We're Reading Reuters UK's COVID-19 test-and-trace system still missing targets-watchdog MedCity News Prisma Health, Siemens strike 10-year partnership TCTMD Is the Heart Team Concept Waning in TAVI? Wall Street Journal Hospital Stocks’ Rally Points to Post-Covid Growth MassDevice Integra Lifesciences CEO steps down to succeed GE Healthcare CEO Murphy Evaluate Vantage Guardant steps into a new arena Suggest a story we should read Dive Into a Topic Medical Devices Policy & Regulation Clinical Trials Manufacturing Legal M&A Research Diagnostics Digital Health Imaging Share MedTech Dive: Daily Dive with others and get rewarded. You've referred 0 readers. To become an official Dive Insider, just successfully refer 10 contacts to MedTech Dive: Daily Dive. Here's your link to share: https://www.medtechdive.com/signup/insiders/?signup_referred_by=5f93078d7aa51972095c9316

More Than A Newsletter Related Publications BioPharma Dive | Healthcare Dive Connect With Us Twitter | LinkedIn Editorial Contact an editor | Meet the team Advertising Contact our team About MedTech Dive MedTech Dive provides in-depth journalism and insight into the most impactful news and trends shaping medical technology. The newsletters and website cover topics such as medical devices, diagnostics, digital health, regulation/compliance, R&D, M&A and more. Medtech Dive is a leading publication operated by Industry Dive. Our business journalists spark ideas and shape agendas for 10+ million decision makers in competitive industries. Sign up for the newsletter This email is optimized for display on mobile phones. MedTech Dive: Daily Dive is a product of Industry Dive, Inc. 1255​ 23rd Street NW, Suite 550, Washington,​ DC 20037. We value your privacy. We won't share your email address with anyone else without your permission. This message was sent to edwardlorilla1986.acciyo123@blogger.com. You can unsubscribe or switch to a weekly newsletter subscription anytime. See our full privacy policy.

Sign up | Manage subscription | Advertise with us | Submit story tip